Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 178 articles: HTML format

Single Articles

April 2024
1. TODA S, Hiroshima Y, Iwasaki H, Masudo K, et al
   Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
   J Clin Endocrinol Metab. 2024 Apr 17:dgae271. doi: 10.1210.
   PubMed     Abstract available
   
   
   
2. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
   TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
   J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
   PubMed     Abstract available
   
   
   March 2024
3. HENSLEY SG, Hu MI, Bassett RL, Ying AK, et al
   Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades.
   J Clin Endocrinol Metab. 2024 Mar 4:dgae133. doi: 10.1210.
   PubMed     Abstract available
   
   
   February 2024
4. JAGANNATH S, Mayilvaganan S
   Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma".
   J Clin Endocrinol Metab. 2024 Feb 29:dgae117. doi: 10.1210.
   PubMed    
   
   
   
5. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
   Response to Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?".
   J Clin Endocrinol Metab. 2024 Feb 28:dgae118. doi: 10.1210.
   PubMed    
   
   
   
6. MAINO F, Botte M, Dalmiglio C, Valerio L, et al
   Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
   J Clin Endocrinol Metab. 2024;109:722-729.
   PubMed     Abstract available
   
   
   
7. STEGENGA MT, van Velsen EFS, Oudijk L, Verburg FA, et al
   Clinical and Histopathological Risk Factors for Radioactive Iodine Refractory Follicular and Oncocytic Thyroid Carcinoma.
   J Clin Endocrinol Metab. 2024 Feb 13:dgae084. doi: 10.1210.
   PubMed     Abstract available
   
   
   December 2023
8. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
   Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
   J Clin Endocrinol Metab. 2023;109:e347-e355.
   PubMed     Abstract available
   
   
   November 2023
9. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
   Role of the degree of vascular invasion in predicting prognosis of follicular thyroid carcinoma.
   J Clin Endocrinol Metab. 2023 Nov 25:dgad689. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. TORA R, Welch J, Sun J, Agarwal SK, et al
    Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    J Clin Endocrinol Metab. 2023;108:3165-3177.
    PubMed     Abstract available
    
    
    
11. LIU Q, Mao L, Zhang Z, Li G, et al
    Diagnostic Efficacy of FNA-Tg in DTC Cervical LN Metastasis and its Impact Factors: A Large Retrospective Study.
    J Clin Endocrinol Metab. 2023;108:3311-3319.
    PubMed     Abstract available
    
    
    
12. FALCHETTI A
    New Perspective on the Genetic Dissection Underlying the Development of Parathyroid Cancer.
    J Clin Endocrinol Metab. 2023;108:e1751-e1752.
    PubMed    
    
    
    
13. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2023
14. KWON H, Han KD, Moon SJ, Park SE, et al
    Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. DAI P, Zhao W, Zheng X, Luo H, et al
    Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant.
    J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
    PubMed     Abstract available
    
    
    
16. 
    Correction to "The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation".
    J Clin Endocrinol Metab. 2023 Oct 3:dgad573. doi: 10.1210.
    PubMed    
    
    
    September 2023
17. PALYGA I, Rumian M, Kosel A, Albrzykowski M, et al
    The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy.
    J Clin Endocrinol Metab. 2023 Sep 28:dgad571. doi: 10.1210.
    PubMed     Abstract available
    
    
    
18. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    PubMed     Abstract available
    
    
    
19. POZDEYEV N, Dighe M, Barrio M, Raeburn C, et al
    Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant.
    J Clin Endocrinol Metab. 2023 Sep 8:dgad530. doi: 10.1210.
    PubMed     Abstract available
    
    
    
20. ILGAN S, Aydogan BI, Emer O, Anil C, et al
    Sonographic features of atypical and initially missed parathyroid adenomas: Lessons learned from a single center cohort.
    J Clin Endocrinol Metab. 2023 Sep 5:dgad527. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2023
21. GILLIS A, Chen H, Wang TS, Dream S, et al
    Racial and Ethnic Disparities in the Diagnosis and Treatment of Thyroid Disease: a Mini- Review.
    J Clin Endocrinol Metab. 2023 Aug 30:dgad519. doi: 10.1210.
    PubMed     Abstract available
    
    
    
22. HA EJ, Lee JH, Lee DH, Moon J, et al
    Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad503. doi: 10.1210.
    PubMed     Abstract available
    
    
    
23. JU G, Sun Y, Wang H, Zhang X, et al
    Fusion oncogenes in patients with locally advanced or distant metastatic differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad500. doi: 10.1210.
    PubMed     Abstract available
    
    
    
24. MACHENS A, Lorenz K, Brandenburg T, Fuhrer-Sakel D, et al
    The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine.
    J Clin Endocrinol Metab. 2023;108:e734-e742.
    PubMed     Abstract available
    
    
    
25. LI H, Han R, Meng L, Sun Y, et al
    Nodal Metastases Associated with Fusion Oncogenes Are Age Dependent in Young Adult Patients with Thyroid Cancer.
    J Clin Endocrinol Metab. 2023 Aug 3:dgad458. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. CETANI F, Pardi E, Torregrossa L, Borsari S, et al
    Approach to the Patient With Parathyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Aug 2:dgad455. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2023
27. WANG JR, Zafereo ME, Wang W, Joshu C, et al
    Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad407. doi: 10.1210.
    PubMed     Abstract available
    
    
    
28. MERCADO M
    The Role of Androgen Receptors in Thyroid Cancer Biology: Beyond Sexual Dimorphism.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad424. doi: 10.1210.
    PubMed    
    
    
    
29. TIAN T, Qi Z, Huang S, Wang H, et al
    Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
    J Clin Endocrinol Metab. 2023;108:2033-2041.
    PubMed     Abstract available
    
    
    
30. NOEL JE, Sinclair CF
    Radiofrequency Ablation for Benign Thyroid Nodules.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad357. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2023
31. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
    J Clin Endocrinol Metab. 2023 Jun 23:dgad369. doi: 10.1210.
    PubMed     Abstract available
    
    
    
32. SHAHA AR
    Aggressive Subtypes of Papillary Microcarcinoma.
    J Clin Endocrinol Metab. 2023;108:e489-e490.
    PubMed    
    
    
    
33. XIANG P, Ahmadi S, Coleman A, West W, et al
    Identifying and Predicting Diverse Patterns of Benign Nodule Growth.
    J Clin Endocrinol Metab. 2023;108:e458-e463.
    PubMed     Abstract available
    
    
    
34. TAO X, Xu T, Lin X, Xu S, et al
    Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    J Clin Endocrinol Metab. 2023;108:1768-1775.
    PubMed     Abstract available
    
    
    
35. YAN L, Zhen Y, Li Y, Li X, et al
    Five-year Outcome Between Radiofrequency Ablation vs. Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad360. doi: 10.1210.
    PubMed     Abstract available
    
    
    
36. YEH MW
    The molecular landscape of thyroid nodules: Diagnostic and prognostic revelations from a large multicenter cohort.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad362. doi: 10.1210.
    PubMed    
    
    
    
37. SATAPATHY S, Majeed AK, Ballal S, Bal C, et al
    Differentiated thyroid cancers in young adults versus children: Clinical characteristics and ten-year follow-up outcomes.
    J Clin Endocrinol Metab. 2023 Jun 7:dgad343. doi: 10.1210.
    PubMed     Abstract available
    
    
    
38. SGRO D, Brancatella A, Greco G, Torregrossa L, et al
    Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad313. doi: 10.1210.
    PubMed     Abstract available
    
    
    
39. ZHOU Y, Wang Y, Zhang Z, Yin X, et al
    Male sex is not a risk factor for prognosis in postoperative thyroid cancer patients: a propensity score matching study.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad314. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. BOJARSKY M, Baran JA, Halada S, Isaza A, et al
    Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad322. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2023
41. LIN Y, Wu ZR, Shi YP, Ding M, et al
    Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
    J Clin Endocrinol Metab. 2023 May 23:dgad269. doi: 10.1210.
    PubMed     Abstract available
    
    
    
42. CHOU CK, Chi SY, Hung YY, Yang YC, et al
    Clinical impact of androgen receptor-suppressing miR-146b expression in papillary thyroid cancer aggressiveness.
    J Clin Endocrinol Metab. 2023 May 23:dgad279. doi: 10.1210.
    PubMed     Abstract available
    
    
    
43. ALZAHRANI AS
    Clinical use of molecular data in thyroid nodules and cancer.
    J Clin Endocrinol Metab. 2023 May 18:dgad282. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. NASR CE, Andrioli M, Endo M, Harrell RM, et al
    Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.
    J Clin Endocrinol Metab. 2023;108:1526-1532.
    PubMed     Abstract available
    
    
    
45. SUN Y, Sun Q, Tian J, He X, et al
    Impact of waiting time for radioactive iodine therapy on outcome in N1 stage papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 May 11:dgad264. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2023
46. ULLMANN TM, Sosa JA
    Delay in Surgery for Papillary Thyroid Cancer: A Proxy for Lower-Quality Care?
    J Clin Endocrinol Metab. 2023 Apr 21:dgad232. doi: 10.1210.
    PubMed    
    
    
    
47. CHIOSEA S, Hodak SP, Yip L, Abraham D, et al
    Molecular Profiling of 50,734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
    J Clin Endocrinol Metab. 2023 Apr 18:dgad220. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2023
48. ALSWAILEM M, Alghamdi B, Alotaibi A, Aljomiah A, et al
    Molecular genetics of diffuse sclerosing papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad185. doi: 10.1210.
    PubMed     Abstract available
    
    
    
49. KIM NE, Raghunathan RS, Hughes EG, Longstaff XR, et al
    Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210.
    PubMed     Abstract available
    
    
    
50. ALZAHRANI AS
    The risk of expanding risk stratification in thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad182. doi: 10.1210.
    PubMed    
    
    
    
51. CHAVES N, Broekhuis JM, Fligor SC, Collins RA, et al
    Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: a SEER-Medicare Analysis.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad163. doi: 10.1210.
    PubMed     Abstract available
    
    
    
52. VAN VELSEN EFS, Verburg FA
    Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad171. doi: 10.1210.
    PubMed    
    
    
    
53. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
    Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad173. doi: 10.1210.
    PubMed     Abstract available
    
    
    
54. NASR CE
    Can one predict long-term growth of cytologically-benign thyroid nodules?
    J Clin Endocrinol Metab. 2023 Mar 22:dgad160. doi: 10.1210.
    PubMed    
    
    
    
55. JHA S, Welch J, Tora R, Lack J, et al
    Germline and somatic inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors.
    J Clin Endocrinol Metab. 2023 Mar 20:dgad136. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2023
56. GRANI G, Del Gatto V, Cantisani V, Mandel SJ, et al
    A reappraisal of suspicious sonographic features of thyroid nodules: shape is not an independent predictor of malignancy.
    J Clin Endocrinol Metab. 2023 Feb 22:dgad092. doi: 10.1210.
    PubMed     Abstract available
    
    
    
57. GRANI G, Gentili M, Siciliano F, Albano D, et al
    A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study.
    J Clin Endocrinol Metab. 2023 Feb 16:dgad075. doi: 10.1210.
    PubMed     Abstract available
    
    
    
58. SEISA MO, Nayfeh T, Hasan B, Firwana M, et al
    A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults.
    J Clin Endocrinol Metab. 2023;108:585-591.
    PubMed     Abstract available
    
    
    
59. PRETE A, Gambale C, Torregrossa L, Ciampi R, et al
    Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment.
    J Clin Endocrinol Metab. 2023 Feb 1:dgad061. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2023
60. PRAW SS, Brent GA
    Approach to the Patient With a Suppressed TSH.
    J Clin Endocrinol Metab. 2023;108:472-482.
    PubMed     Abstract available
    
    
    
61. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Response to Letter to the Editor from Yang et al.: "Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    J Clin Endocrinol Metab. 2023 Jan 6:dgac754. doi: 10.1210.
    PubMed    
    
    
    
62. YANG S, Tan M, Gao F, Xu X, et al
    Letter to the Editor from Yang et al.: "Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    J Clin Endocrinol Metab. 2023 Jan 2:dgac753. doi: 10.1210.
    PubMed    
    
    
    December 2022
63. MAJEED AK, Satapathy S, Ballal S, Bal C, et al
    Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Dec 29:dgac731. doi: 10.1210.
    PubMed     Abstract available
    
    
    
64. ZHANG X, Liu JR, Mu ZZ, Cheng XQ, et al
    Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-risk Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2022 Dec 26:dgac745. doi: 10.1210.
    PubMed     Abstract available
    
    
    
65. LEE JS, Lee JS, Yun HJ, Kim SM, et al
    Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm.
    J Clin Endocrinol Metab. 2022 Dec 21:dgac739. doi: 10.1210.
    PubMed     Abstract available
    
    
    
66. RANA C, Bychkov A
    NIFTP Statistics-Now You See It, Now You Don't.
    J Clin Endocrinol Metab. 2022;108:e5-e6.
    PubMed    
    
    
    
67. VAN VELSEN EFS, Peeters RP, Stegenga MT, van Kemenade FJ, et al
    Evaluating Disease Specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2022 Dec 12:dgac721. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2022
68. PEREZ MN, Halada S, Isaza A, Sisko L, et al
    Health-Related Quality of Life at Diagnosis for Pediatric Thyroid Cancer Patients.
    J Clin Endocrinol Metab. 2022 Nov 4. pii: 6795528. doi: 10.1210.
    PubMed     Abstract available
    
    
    
69. ULLMANN TM, Papaleontiou M, Sosa JA
    Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.
    J Clin Endocrinol Metab. 2022 Nov 3. pii: 6795262. doi: 10.1210.
    PubMed     Abstract available
    
    
    
70. BROEKHUIS JM, James BC
    Delays in Surgery for Differentiated Thyroid Carcinomas: How Long is Reasonable, and What Questions Remain?
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785940. doi: 10.1210.
    PubMed    
    
    
    October 2022
71. TIAN T, Huang S, Dai H, Qi M, et al
    Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid Cancer in Child, Adolescent, and Young Adult.
    J Clin Endocrinol Metab. 2022 Oct 13. pii: 6760001. doi: 10.1210.
    PubMed     Abstract available
    
    
    
72. RIVKEES SA
    Approach to the Patient: Management and the Long-Term Consequences of Graves' Disease in Children.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6746564. doi: 10.1210.
    PubMed     Abstract available
    
    
    
73. MA B, Wen S, Luo Y, Zhang T, et al
    Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6747527. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2022
74. ANGELL TE, Kwon DI
    Finding the Balance on Extent of Initial Thyroidectomy for Low-Risk Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Sep 22. pii: 6711571. doi: 10.1210.
    PubMed    
    
    
    
75. PALERMO A, Sodo A, Naciu AM, Gioacchino MD, et al
    Clinical use of Raman spectroscopy improves diagnostic accuracy for indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6697971. doi: 10.1210.
    PubMed     Abstract available
    
    
    
76. PALERMO A, Cesareo R
    Response to Letter to the Editor from Xu and Yang: Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules:12-Month Results of a Randomized Trial (LARA II Study).
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691130. doi: 10.1210.
    PubMed    
    
    
    
77. ZHOU H, Wu J, Shi L, Wang Y, et al
    Analysis of delayed surgery and clinical outcomes in intermediate- and high-risk papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691129. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2022
78. MA X, Ma X, Chin L, Zhu Z, et al
    A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
    J Clin Endocrinol Metab. 2022;107:2636-2643.
    PubMed     Abstract available
    
    
    
79. ARROYO N, Bell KJL, Hsiao V, Fernandes-Taylor S, et al
    Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.
    J Clin Endocrinol Metab. 2022 Aug 10. pii: 6659928. doi: 10.1210.
    PubMed     Abstract available
    
    
    
80. CHEN DW, Rob FI, Mukherjee R, Giordano TJ, et al
    Variation in the diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    J Clin Endocrinol Metab. 2022 Aug 3. pii: 6653515. doi: 10.1210.
    PubMed     Abstract available
    
    
    
81. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Prevalence of Postoperatively-Detected High-Risk Features in 2-4cm Papillary Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Aug 1. pii: 6653085. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2022
82. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy does not improve cancer-specific survival in Hurthle cell carcinoma of the thyroid.
    J Clin Endocrinol Metab. 2022 Jul 31. pii: 6652584. doi: 10.1210.
    PubMed     Abstract available
    
    
    
83. OMIDAKHSH N, Heck JE, Cockburn M, Ling C, et al
    Thyroid Cancer and Pesticide Use in a Central California Agricultural Area: A Case Control Study.
    J Clin Endocrinol Metab. 2022 Jul 26. pii: 6650257. doi: 10.1210.
    PubMed     Abstract available
    
    
    
84. 
    Correction to: Lenvatinib Targets PDGFR-beta Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
    J Clin Endocrinol Metab. 2022 Jul 8. pii: 6633918. doi: 10.1210.
    PubMed    
    
    
    June 2022
85. ALZAHRANI AS, Alswailem M, Alghamdi B, Al-Hindi H, et al
    Fumarate hydratase is a novel gene for familial non-medullary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 25. pii: 6618018. doi: 10.1210.
    PubMed     Abstract available
    
    
    
86. WANG K, Liu S, Tian Y, Liu C, et al
    PDZK1 interacting protein 1 (PDZK1IP1) promotes the progression of papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 21. pii: 6612492. doi: 10.1210.
    PubMed     Abstract available
    
    
    
87. SAVVATEEVA M, Kudryavtseva A, Lukyanova E, Kobelyatskaya A, et al
    Somatic Mutation Profiling in Head and Neck Paragangliomas.
    J Clin Endocrinol Metab. 2022;107:1833-1842.
    PubMed     Abstract available
    
    
    
88. TSANG V, Gill A, Gild M, Lurie B, et al
    Selpercatinib treatment of RET mutated thyroid cancers is associated with gastrointestinal adverse effects.
    J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596759. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2022
89. ELISEI R, Ciampi R, Matrone A, Prete A, et al
    Somatic Ret Indels In Sporadic Medullary Thyroid Cancer: Prevalence And Response To Selpercatinib.
    J Clin Endocrinol Metab. 2022 May 25. pii: 6591888. doi: 10.1210.
    PubMed     Abstract available
    
    
    
90. GLASGOW C, Lau EYC, Aloj L, Harper I, et al
    An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    J Clin Endocrinol Metab. 2022;107:1706-1713.
    PubMed     Abstract available
    
    
    
91. VIOLA D, Poma AM, Elisei R, Basolo F, et al
    Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2653-e2654.
    PubMed    
    
    
    
92. GREEN M, Gosmanov AR
    Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should Not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2647-e2648.
    PubMed    
    
    
    
93. SOE MH, Chiang JM, Flavell RR, Khanafshar E, et al
    Non-iodine Avid Disease is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer with Papillary Histology.
    J Clin Endocrinol Metab. 2022 May 12. pii: 6584960. doi: 10.1210.
    PubMed     Abstract available
    
    
    
94. BURGOS N, Zhao J, Brito JP, Hoang JK, et al
    Clinician agreement on the classification of thyroid nodules ultrasound features: A survey of two endocrine societies.
    J Clin Endocrinol Metab. 2022 May 6. pii: 6581574. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2022
95. CIAMPI R, Romei C, Ramone T, Matrone A, et al
    Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Apr 26. pii: 6574259. doi: 10.1210.
    PubMed     Abstract available
    
    
    
96. VINCZE S, Peters NV, Kuo CL, Brown TC, et al
    GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2022;107:e2021-e2026.
    PubMed     Abstract available
    
    
    
97. PAPPA T, Ahmadi S, Bikas A, Hwang S, et al
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab. 2022 Apr 19. pii: 6570820. doi: 10.1210.
    PubMed     Abstract available
    
    
    
98. PAPARODIS RD, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Large, slowly growing, benign thyroid nodules frequently coexist with synchronous thyroid cancers.
    J Clin Endocrinol Metab. 2022 Apr 18. pii: 6570003. doi: 10.1210.
    PubMed     Abstract available
    
    
    
99. ULLMANN TM, Duh QY
    Isolated Lateral Neck Nodal Metastases in Patients with Papillary Thyroid Cancer: Does Cervical Compartment Matter?
    J Clin Endocrinol Metab. 2022 Apr 12. pii: 6567539. doi: 10.1210.
    PubMed    
    
    
    
100. HUANG L, Feng X, Yang W, Li X, et al
     Appraising the effect of potential risk factors on thyroid cancer: A Mendelian randomization study.
     J Clin Endocrinol Metab. 2022 Apr 2. pii: 6562772. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2022
101. ZHAO ZL, Wei Y, Peng LL, Li Y, et al
     Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules - Risk Factors and Cause Analysis.
     J Clin Endocrinol Metab. 2022 Mar 21. pii: 6551221. doi: 10.1210.
     PubMed     Abstract available
     
     
     
102. BOUCAI L, Tuttle RM
     Letter to the Editor from Boucai, L and Tuttle, RM: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
     J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545312. doi: 10.1210.
     PubMed    
     
     
     
103. XING M
     Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
     J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545262. doi: 10.1210.
     PubMed    
     
     
     February 2022
104. WENG HY, Yan T, Qiu WW, Fan YB, et al
     The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis.
     J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537119. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2022
105. ALEXANDER EK
     Novel Genomic Roadmaps and Their Clinical Translation Ahead.
     J Clin Endocrinol Metab. 2022;107:e886-e887.
     PubMed    
     
     
     
106. HAY ID, Lee RA, Charboneau JW
     Efficacy of ethanol ablation in long-term local control of neck nodal metastases in adult papillary thyroid carcinoma.
     J Clin Endocrinol Metab. 2022 Jan 14. pii: 6507732. doi: 10.1210.
     PubMed    
     
     
     
107. JANKOVIC MILJUS J, Guillen-Sacoto MA, Makiadi-Alvarado J, Wert-Lamas L, et al
     Circulating MicroRNA Profiles as Potential Biomarkers for differentiated thyroid cancer recurrence.
     J Clin Endocrinol Metab. 2022 Jan 11. pii: 6503735. doi: 10.1210.
     PubMed     Abstract available
     
     
     December 2021
108. STAN MN, Papaleontiou M, Schmitz JJ, Castro MR, et al
     Non-surgical management of thyroid nodules - the role of ablative therapies.
     J Clin Endocrinol Metab. 2021 Dec 25. pii: 6483061. doi: 10.1210.
     PubMed     Abstract available
     
     
     
109. ROTONDI M, Chiovato L
     Pre-existing or concomitant thyroiditis in papillary thyroid cancer: Something more than a mere issue of timing?
     J Clin Endocrinol Metab. 2021 Dec 20. pii: 6470727. doi: 10.1210.
     PubMed    
     
     
     
110. FRICH PS, Sigstad E, Berstad AE, Holgersen KF, et al
     Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma.
     J Clin Endocrinol Metab. 2021 Dec 18. pii: 6469671. doi: 10.1210.
     PubMed     Abstract available
     
     
     
111. ASAMOAH EO, Caraballo G, Castro MR
     Identifying and addressing Health disparities in Thyroid Cancer Care.
     J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454343. doi: 10.1210.
     PubMed    
     
     
     November 2021
112. BOUCAI L, Seshan V, Williams M, Knauf JA, et al
     Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
     J Clin Endocrinol Metab. 2021 Nov 23. pii: 6433608. doi: 10.1210.
     PubMed     Abstract available
     
     
     
113. NIETO HR, Thornton CEM, Brookes K, de Menezes AN, et al
     Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.
     J Clin Endocrinol Metab. 2021 Nov 16. pii: 6429719. doi: 10.1210.
     PubMed     Abstract available
     
     
     
114. WEI Y, Zhao ZL, Wu J, Peng LL, et al
     Response to Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
     J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427797. doi: 10.1210.
     PubMed    
     
     
     
115. YANG S, Xu X
     Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
     J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427798. doi: 10.1210.
     PubMed    
     
     
     
116. LI H, Zhou X, Wang G, Hua D, et al
     CAR-T cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Nov 9. pii: 6423845. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2021
117. ROH E, Noh E, Hwang SY, Kim JA, et al
     Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: A nationwide cohort study.
     J Clin Endocrinol Metab. 2021 Oct 28. pii: 6413717. doi: 10.1210.
     PubMed     Abstract available
     
     
     
118. RADHAKRISHNAN A, Reyes-Gastelum D, Abrahamse P, Gay B, et al
     Physician specialties involved in thyroid cancer diagnosis and treatment: Implications for improving healthcare disparities.
     J Clin Endocrinol Metab. 2021 Oct 26. pii: 6411790. doi: 10.1210.
     PubMed     Abstract available
     
     
     
119. KOH J, Zhang R, Roman S, Duh QY, et al
     Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
     J Clin Endocrinol Metab. 2021;106:3168-3183.
     PubMed     Abstract available
     
     
     
120. SAPONARO F, Pardi E, Mazoni L, Borsari S, et al
     Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
     J Clin Endocrinol Metab. 2021;106:e4565-e4579.
     PubMed     Abstract available
     
     
     
121. NILUBOL N
     "Cutting the Support" to improve treatment efficacy in thyroid cancer by targeting tumor microenvironment.
     J Clin Endocrinol Metab. 2021 Oct 20. pii: 6406379. doi: 10.1210.
     PubMed    
     
     
     
122. BROSE MS, Panaseykin Y, Konda B, de La Fouchardiere C, et al
     A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Oct 19. pii: 6401965. doi: 10.1210.
     PubMed     Abstract available
     
     
     
123. CHANDER NR, Chidambaram S, Van Den Heede K, DiMarco AN, et al
     Correlation of pre-operative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance.
     J Clin Endocrinol Metab. 2021 Oct 13. pii: 6395413. doi: 10.1210.
     PubMed     Abstract available
     
     
     
124. GOLDFARB M, Christison-Lagay E, Rastatter J, Wasserman J, et al
     "Young children are not the same as adolescents when it comes to treating thyroid cancer".
     J Clin Endocrinol Metab. 2021 Oct 5. pii: 6381652. doi: 10.1210.
     PubMed    
     
     
     September 2021
125. SINGH P, Bhadada SK, Dahiya D, Saikia UN, et al
     GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
     J Clin Endocrinol Metab. 2021;106:e4084-e4096.
     PubMed     Abstract available
     
     
     
126. POMA AM, Viola D, Macerola E, Proietti A, et al
     Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
     J Clin Endocrinol Metab. 2021;106:e4109-e4117.
     PubMed     Abstract available
     
     
     
127. LIN S, Zhu Y, Ji C, Yu W, et al
     METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
     J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375332. doi: 10.1210.
     PubMed     Abstract available
     
     
     
128. KIM BW
     Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
     J Clin Endocrinol Metab. 2021 Sep 23. pii: 6374549. doi: 10.1210.
     PubMed     Abstract available
     
     
     
129. DEKKER BL, Links MH, Muller Kobold AC, Swart-Busscher LG, et al
     Low iodine diet of four days is sufficient preparation for 131I therapy in differentiated thyroid cancer patients.
     J Clin Endocrinol Metab. 2021 Sep 17. pii: 6371836. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2021
130. SINGH P, Bhadada SK, Arya AK, Saikia UN, et al
     Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis.
     J Clin Endocrinol Metab. 2021 Aug 28. pii: 6358989. doi: 10.1210.
     PubMed     Abstract available
     
     
     
131. REDLICH A, Luster M, Lorenz K, Lessel L, et al
     Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer.
     J Clin Endocrinol Metab. 2021 Aug 20. pii: 6355728. doi: 10.1210.
     PubMed     Abstract available
     
     
     
132. GIOVANELLA L, Garo ML, Ceriani L, Paone G, et al
     Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. A meta-analysis.
     J Clin Endocrinol Metab. 2021 Aug 12. pii: 6348893. doi: 10.1210.
     PubMed     Abstract available
     
     
     
133. HAYES AR, Crawford A, Al Riyami K, Tang C, et al
     Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
     J Clin Endocrinol Metab. 2021 Aug 11. pii: 6348246. doi: 10.1210.
     PubMed     Abstract available
     
     
     
134. LEE EK, Ahn HY, Ku EJ, Yoo WS, et al
     Cardiovascular outcomes in thyroid cancer patients treated with thyroidectomy: A meta-analysis.
     J Clin Endocrinol Metab. 2021 Aug 4. pii: 6339941. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2021
135. CIAPPUCCINI R, Saguet-Rysanek V, Giffard F, Licaj I, et al
     PSMA expression in differentiated thyroid cancer: association with radioiodine, 18FDG uptake, and patient outcome.
     J Clin Endocrinol Metab. 2021 Jul 31. pii: 6332894. doi: 10.1210.
     PubMed     Abstract available
     
     
     
136. IESATO A, Li S, Roti G, Hacker MR, et al
     Lenvatinib targets PDGFR-beta pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights.
     J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327813. doi: 10.1210.
     PubMed     Abstract available
     
     
     
137. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
     Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
     PubMed     Abstract available
     
     
     
138. TAO Y, Wang F, Shen X, Zhu G, et al
     BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Jul 17. pii: 6323355. doi: 10.1210.
     PubMed     Abstract available
     
     
     
139. GIANI C, Torregrossa L, Ramone T, Romei C, et al
     Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Jul 3. pii: 6291802. doi: 10.1210.
     PubMed     Abstract available
     
     
     
140. YANG S, Xu X
     Letter to the Editor from [Xiequn Xu]: (Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study)).
     J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312741. doi: 10.1210.
     PubMed    
     
     
     June 2021
141. PAULSSON JO, Rafati N, DiLorenzo S, Chen Y, et al
     Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in microRNA processing subunit DGCR8.
     J Clin Endocrinol Metab. 2021 Jun 25. pii: 6309631. doi: 10.1210.
     PubMed     Abstract available
     
     
     
142. RADEBE L, van der Kaay DCM, Wasserman JD, Goldenberg A, et al
     Predicting Malignancy with Pediatric Thyroid Nodules: Early Experience in Machine Learning for Clinical Decision Support.
     J Clin Endocrinol Metab. 2021 Jun 23. pii: 6308313. doi: 10.1210.
     PubMed     Abstract available
     
     
     
143. MANIAKAS A, Henderson YC, Hei H, Peng S, et al
     Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity.
     J Clin Endocrinol Metab. 2021 Jun 19. pii: 6306517. doi: 10.1210.
     PubMed     Abstract available
     
     
     
144. TIAN T, Xu Y, Zhang X, Liu B, et al
     Prognostic implications of pre-ablation stimulated Tg: a retrospective analysis of 2500 thyroid cancer patients.
     J Clin Endocrinol Metab. 2021 Jun 18. pii: 6304758. doi: 10.1210.
     PubMed     Abstract available
     
     
     
145. LIMBACH AL, Sipos JA
     Indeterminate thyroid nodules: the hazy genomic landscape coming into focus.
     J Clin Endocrinol Metab. 2021 Jun 16. pii: 6303548. doi: 10.1210.
     PubMed    
     
     
     
146. HENDERSON YC, Mohamed ASR, Maniakas A, Chen Y, et al
     A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
     J Clin Endocrinol Metab. 2021 Jun 12. pii: 6297567. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2021
147. HU MI, Waguespack SG, Dosiou C, Ladenson PW, et al
     Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
     J Clin Endocrinol Metab. 2021 May 19. pii: 6278308. doi: 10.1210.
     PubMed     Abstract available
     
     
     
148. SUTEAU V, Seegers V, Munier M, Ben Boubaker R, et al
     G Protein-Coupled Receptors in radioiodine-refractory thyroid cancer in the Era of Precision Medicine.
     J Clin Endocrinol Metab. 2021 May 17. pii: 6277036. doi: 10.1210.
     PubMed     Abstract available
     
     
     
149. PITT SC, Haymart MR
     Breaking Down or Waking Up? Psychological Distress and Sleep Disturbance in Patients with Thyroid Nodules and Cancer.
     J Clin Endocrinol Metab. 2021 May 13. pii: 6274981. doi: 10.1210.
     PubMed    
     
     
     
150. RAUE F, Bruckner T, Frank-Raue K
     Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma.
     J Clin Endocrinol Metab. 2021 May 11. pii: 6273583. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2021
151. VALERIO L, Guidoccio F, Giani C, Tardelli E, et al
     [ 18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patients' survival.
     J Clin Endocrinol Metab. 2021 Apr 26. pii: 6253809. doi: 10.1210.
     PubMed     Abstract available
     
     
     
152. LI R, Li G, Wang Y, Bao T, et al
     Psychological distress and sleep disturbance throughout thyroid nodules screening, diagnosis and treatment.
     J Clin Endocrinol Metab. 2021 Apr 8. pii: 6217326. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2021
153. MACHENS A, Lorenz K, Weber F, Dralle H, et al
     Exceptionality of Distant Metastases in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
     J Clin Endocrinol Metab. 2021 Mar 31. pii: 6206751. doi: 10.1210.
     PubMed     Abstract available
     
     
     
154. CHERELLA CE, Richman DM, Liu E, Frates MC, et al
     Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Mar 29. pii: 6199870. doi: 10.1210.
     PubMed     Abstract available
     
     
     
155. LIN YS, Zhang X, Wang C, Liu YQ, et al
     Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer.
     J Clin Endocrinol Metab. 2021 Mar 26. pii: 6189101. doi: 10.1210.
     PubMed     Abstract available
     
     
     
156. SEO GH, Ae Kong K, Kim BS, Seo YK, et al
     Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-Based Study.
     J Clin Endocrinol Metab. 2021 Mar 23. pii: 6184125. doi: 10.1210.
     PubMed     Abstract available
     
     
     
157. WALLNER LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al
     Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer.
     J Clin Endocrinol Metab. 2021 Mar 4. pii: 6158968. doi: 10.1210.
     PubMed     Abstract available
     
     
     
158. XI C, Zhang Q, Song HJ, Shen CT, et al
     Pregnancy does not affect the Prognoses of Differentiated Thyroid Cancer Patients with Lung Metastases.
     J Clin Endocrinol Metab. 2021 Mar 1. pii: 6155712. doi: 10.1210.
     PubMed     Abstract available
     
     
     February 2021
159. CHEN DW, Reyes-Gastelum D, Hawley ST, Wallner LP, et al
     Unmet Information Needs Among Hispanic Women with Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154483. doi: 10.1210.
     PubMed     Abstract available
     
     
     
160. LI CW, Shi X, Ma B, Wang YL, et al
     A Four Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
     J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154371. doi: 10.1210.
     PubMed     Abstract available
     
     
     
161. CESAREO R, Manfrini S, Pasqualini V, Ambrogi C, et al
     Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study).
     J Clin Endocrinol Metab. 2021 Feb 20. pii: 6145113. doi: 10.1210.
     PubMed     Abstract available
     
     
     
162. ALEXANDER EK
     From the Tip to the Iceberg below - Evolving our Molecular Understanding of Thyroid Nodules.
     J Clin Endocrinol Metab. 2021 Feb 16. pii: 6137555. doi: 10.1210.
     PubMed    
     
     
     
163. CHEN D, Tan Y, Li Z, Li W, et al
     Organoid cultures derived from patients with papillary thyroid cancer.
     J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125726. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2021
164. PANAGIOTOU G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al
     Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans.
     J Clin Endocrinol Metab. 2021 Jan 25. pii: 6119546. doi: 10.1210.
     PubMed     Abstract available
     
     
     
165. DUTTA S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, et al
     Plasma cell free DNA to differentiate malignant from benign thyroid nodules.
     J Clin Endocrinol Metab. 2021 Jan 21. pii: 6105060. doi: 10.1210.
     PubMed     Abstract available
     
     
     
166. CHONG AS, Nikiforov YE, Condello V, Wald AI, et al
     Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology.
     J Clin Endocrinol Metab. 2021 Jan 18. pii: 6103949. doi: 10.1210.
     PubMed     Abstract available
     
     
     
167. ZHANG L, Ren Z, Su Z, Liu Y, et al
     Novel recurrent altered genes in Chinese patients with anaplastic thyroid cancer.
     J Clin Endocrinol Metab. 2021 Jan 11. pii: 6082745. doi: 10.1210.
     PubMed     Abstract available
     
     
     
168. MURPHY CF, Stratford N, Docherty NG, Moran B, et al
     A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
     J Clin Endocrinol Metab. 2021;106:e204-e216.
     PubMed     Abstract available
     
     
     December 2020
169. GRANI G, Lamartina L, AlfO M, Ramundo V, et al
     Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk.
     J Clin Endocrinol Metab. 2020 Dec 30. pii: 6055578. doi: 10.1210.
     PubMed     Abstract available
     
     
     
170. PITT SC, Yang N, Saucke MC, Marka N, et al
     Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
     J Clin Endocrinol Metab. 2020 Dec 29. pii: 6054975. doi: 10.1210.
     PubMed     Abstract available
     
     
     
171. ZHU CY, Donangelo I, Gupta D, Nguyen DT, et al
     Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
     J Clin Endocrinol Metab. 2020 Dec 2. pii: 6015927. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2020
172. MOON JH, Ryu CH, Cho SW, Choi JY, et al
     Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma.
     J Clin Endocrinol Metab. 2020 Nov 28. pii: 6009064. doi: 10.1210.
     PubMed     Abstract available
     
     
     
173. CAPEZZONE M, Sagnella A, Pilli T, Maino F, et al
     Role of Age at Diagnosis in Defining Potential Familial Non-Medullary Thyroid Cancer in Kindreds with Only Two Affected Members.
     J Clin Endocrinol Metab. 2020 Nov 11. pii: 5974121. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2020
174. WASSNER AJ
     Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy.
     J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943497. doi: 10.1210.
     PubMed    
     
     
     
175. BROOME DT, Naples R, Bailey R, Tekin Z, et al
     Use of Preoperative Imaging in Primary Hyperparathyroidism.
     J Clin Endocrinol Metab. 2020 Oct 29. pii: 5942949. doi: 10.1210.
     PubMed     Abstract available
     
     
     
176. YANG S, Jin C, Xu X
     Letter to the Editor from Shijie Yang et al: US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study.
     J Clin Endocrinol Metab. 2020 Oct 22. pii: 5936021. doi: 10.1210.
     PubMed    
     
     
     September 2020
177. SHI X, Li CW, Tan LC, Wen SS, et al
     Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3 and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
     J Clin Endocrinol Metab. 2020 Sep 30. pii: 5916419. doi: 10.1210.
     PubMed     Abstract available
     
     
     
178. RINGEL MD
     New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
     J Clin Endocrinol Metab. 2020 Sep 25. pii: 5911817. doi: 10.1210.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.